Cited by 23Medication Adherence and CompliancePharmacy and Medical PracticesPharmaceutical Practices and Patient Outcomes

Community pharmacist interventions to improve adherence to lipid lowering medication and their influence on clinical outcomes: A systematic review and meta‐analysis

Oñatibia‐Astibia, Ainhoa, Malet‐Larrea, Amaia, Gastelurrutia, Miguel Ángel, Calvo, Begoña, Goyenechea, Estibaliz·2021·Journal of Evaluation in Clinical Practice

Abstract

Introduction Non-adherence is a major problem among patients with chronic diseases. Community pharmacists are ideally positioned to detect non-adherence and to provide patient-centred interventions. Objective To conduct a systematic review of the impact of community pharmacist interventions on patient adherence to lipid lowering medication (LLM) prescriptions and clinical outcomes. Search method Five databases (MEDLINE, Cochrane Library, Science Direct, Scopus, and Web of Knowledge) were searched systematically to identify relevant reports published by December 2019. Study quality was assessed with the Cochrane risk of bias (RoB 2.0) tool. Selection criteria Controlled trials in which community pharmacists conducted an intervention to improve patient adherence to LLM and clinical outcomes were evaluated. Main results Five studies (2408 participants) were included in the qualitative analysis. Four studies (n = 2266) were pooled in the meta-analysis. Participants in the intervention group (IG) had better adherence than those in the control group (CG) [odds ratio (OR) = 1.67; 95% confidence interval (CI) 1.38-2.02; P 2 = 54%]. Better adherence rates were obtained when adherence was measured with validated questionnaires than when medication-possession ratio (MPR) measurements were used. Total cholesterol (TC) levels were not included in the meta-analysis due to data variability among the studies. Conclusions Pharmacist-led intervention can improve LLM adherence, but its influenc…

Integrity signals

Registry

Crossref · 10.1111/jep.13451

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Oñatibia-Astibia et al., 2021 focused on the potential of community pharmacist interventions on improving adherence to LLMs and clinical outcomes, but their impact on clinically-relevant outcomes remains insufficiently explored.

    “Oñatibia-Astibia et al., 2021 focused on the potential of community pharmacist interventions on improving adherence to LLMs and clinical outcomes.7 However, their impact on clinically-relevant outcomes remains insufficiently explored.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Oñatibia‐Astibia, A., Malet‐Larrea, A., Gastelurrutia, M. Á., Calvo, B., & Goyenechea, E.
Affiliations
  • University of the Basque Country (ES)
  • Official Pharmacist Association of Gipuzkoa San Sebastian Spain
  • Universidad de Granada (ES)
Corresponding author
Oñatibia‐Astibia, Ainhoa
Venue
Journal of Evaluation in Clinical Practice
Publisher
Wiley
Published
2020-09-02
Volume
27
Issue
2
Pages
451-463
ISSN
  • 1356-1294 (ISSN-L)
  • 1365-2753
OpenAlex
W3083530269
Cited by
23
References
4
Citations by year
2026: 5 · 2025: 4 · 2024: 4 · 2023: 4 · 2022: 3 · 2021: 3
FWCI
0.52
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Evaluation in Clinical Practice (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
community pharmacists, pharmacist intervention, medication adherence, lipid-lowering drugs, hyperlipidemia, cholesterol management, medication possession ratio, adherence questionnaires, clinical outcomes
MeSH terms
Humans, Lipids, Pharmacists, Medication Adherence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review